Global single-use assemblies market is expected to reach US$ 34.73 Bn by 2030, from US$ 11.03 Bn in 2023, exhibiting a CAGR of 17.8% during the forecast period.
Global Single-use Assemblies Market - Restraints
The high initial investment required for setting up single-use production lines and facilities by biopharmaceutical manufacturers is also slowing the adoption rate. Significant capital is needed for purchasing assemblies, installation of required equipment such as plastic welding machines, assembly robots, and sterile manufacturing suites. Additionally, frequent production line clearances and changeovers further inflate the operational costs. These substantial expenses pose serious budgetary challenges, especially for small and medium-sized biopharmaceutical companies with limited financial resources. As a result, some drug developers prefer conventional stainless-steel based reusable equipment over single-use technologies for large-scale commercial production.
Having a diverse range of non-standardized manufacturing procedures also increases the compliance burden and operational costs for bio manufacturers. They have to validate and qualify every new vendor and product individually due to differences in manufacturing and quality standards. This leads to longer approval cycles and delays in setting up new production lines or making vendor changes. It also prevents the feasible and timely scale-up of manufacturing during periods of high demand like the ongoing COVID pandemic. With standardized manufacturing under a harmonized framework, the changes and additions of new contract manufacturing partners could be done more efficiently and swiftly to meet any unexpected rise in market requirements.
Figure 2. Global Single-use Assemblies Market Share (%), By Product, 2023
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients